Delaware Senate Panel Advances Hospital Medical Cannabis Access Bill

The Delaware Senate Health & Social Services Committee approved legislation Tuesday that would grant terminally ill patients the right to use medical cannabis while receiving care in hospitals and healthcare facilities.

Sen. Marie Pinkney (D) sponsored the measure, which passed the committee with an amendment clarifying the scope of where and how patients could access their medicine. "This is a compassionate measure," Pinkney said during committee proceedings.

The bill addresses a gap in Delaware's existing medical marijuana program, which has operated since 2011 but lacks explicit protections for patients seeking to use cannabis in institutional settings. Currently, hospitals can—and often do—prohibit medical cannabis use even for patients with qualifying conditions, forcing some terminally ill individuals to choose between their prescribed treatment and facility care.

What The Bill Changes

Under the proposed legislation, healthcare facilities would be required to accommodate medical cannabis patients who meet specific criteria. The amendment adopted Tuesday narrowed the bill's focus to terminally ill patients specifically, rather than all medical marijuana cardholders.

Delaware's medical cannabis program serves approximately 20,000 registered patients across the state. The program recognizes conditions including cancer, HIV/AIDS, and other debilitating diseases—many of which require extended hospital stays during end-of-life care.

The Compassionate Care Argument

Advocates for the measure argue that denying terminally ill patients access to their prescribed cannabis treatment during hospitalization creates unnecessary suffering. Many patients rely on cannabis to manage pain, nausea, and appetite loss associated with both their underlying conditions and treatments like chemotherapy.

The legislation comes as healthcare facilities nationwide grapple with how to handle medical cannabis in states where it's legal. Federal prohibition complicates matters, as many hospitals receive federal funding and fear jeopardizing that support by allowing cannabis use on premises.

Yet several states have moved forward with similar protections. New York, New Jersey, and Pennsylvania have all enacted laws requiring or permitting medical cannabis access in certain healthcare settings, particularly for palliative care patients.

What Happens Next

The bill now advances to the full Senate for consideration. If it clears that chamber, it would move to the House of Representatives before reaching Gov. John Carney's desk.

Timing matters for Delaware's cannabis landscape. The state launched adult-use sales in 2024 after voters approved recreational legalization in 2022. That program has generated significant tax revenue and expanded access, but medical patients still face restrictions in institutional settings.

The Senate committee's approval signals growing recognition among Delaware lawmakers that medical cannabis patients deserve the same treatment autonomy as those using other prescribed medications. But questions remain about implementation—including how facilities would handle consumption methods, storage protocols, and staff training.

Pinkney's office has not yet released details on when the full Senate might vote on the measure.

This article is based on original reporting by www.marijuanamoment.net.